A groundbreaking new British drug offers hope to opioid addicts
Buvidal, an injectable form of Buprenorphine, acts as a slow-release drug and blocks the opioid receptors in the brain which stops the patients from having withdrawal symptoms.
Buvidal, an injectable form of Buprenorphine, acts as a slow-release drug and blocks the opioid receptors in the brain which stops the patients from having withdrawal symptoms.
Comment
expand_more
expand_less